SKB Cases Names Tracy Richardson Senior Vice President of Commercial Sales, Announces Sales Team Optimization
ORANGE, CA, UNITED STATES, May 8, 2025 / EINPresswire.com / -- SKB Cases has announced the appointment of Tracy Richardson as Senior Vice President of Commercial Accounts. Tracy joins SKB as a seasoned sales leader with nearly two decades of experience driving commercial and government business growth in the rugged protective case and tactical gear industry.
'Tracy's track record of success in this industry is undeniable,' said John Saxon, SKB's CEO. 'We are confident she is the right person to lead SKB's commercial sales team in its mission of delivering the world's best cases—and customer service—to all the diverse markets and verticals we serve.'
Most recently, Tracy served as Director of National Sales – US, Commercial and Government Divisions at NANUK, where she spent over five years expanding market share, strengthening key account relationships, and leading national sales strategy. Prior to NANUK, Tracy was Vice President at Westminster Inc., where she led high-performing sales teams and delivered consistent revenue growth. She also held a pivotal sales leadership role at Pelican Products, Inc. for over eight years, managing West Coast commercial sales and building a reputation for deep industry expertise and customer-first focus.
'Tracy brings to SKB a unique blend of strategic vision, tactical execution, and passion for delivering value to end users across a wide range of industries,' shared SKB Cases President and COO, Daniel Jewell. 'We're excited to have her on board as we continue our journey of innovation and growth.'
In addition to bringing on Tracy Richardson, SKB will optimize the sales team to shift focus to two strategic divisions: Commercial Accounts and Consumer Accounts.
Juana Quezada will now be the VP of Inside Sales and Customer Experience. Starting her career in the accounting department at SKB, Juana has spent more than 30 years in leadership roles across departments. She embodies a wealth of experience in manufacturing and sales processes, and has been fundamental in cultivating the relationships that have been important drivers of SKB's success. In her new role, Juana will serve as the lead for key accounts management and special projects for both Commercial and Consumer Accounts.
Heading up the Consumer Sales division is Will Steven, VP of Consumer Accounts. Will started at SKB in 2013 as the product manager for the Music division where he built a reputation for innovative product development that greatly expanded SKB's offerings in Photo/Video and Pro A/V markets, and established SKB as the premier protective case supplier for these customers. In this new role, he will oversee the sales teams for all consumer-focused product verticals, including Music, Pro AV, Photo/Video, and Sports.
Steve Kerpan will continue to service the Sporting Goods side of Consumer Accounts as Director of Sports Sales, under Will Steven. Steve joined SKB in 2008, where he helped shape the Sports division by partnering with key industry brands and establishing SKB cases as the customer-favorite protective case for archery and shooting sports. Throughout his tenure at SKB, Steve has worked to develop and maintain critical relationships with brand partners, distributors, dealer networks, and collaborators within the industry to uphold and champion the SKB brand; he will continue to do so as a part of the Consumer Accounts division.
###
About SKB Cases: The first SKB case was created in 1977 by Steve Kottman and Dave Sanderson, who engineered what would eventually become the industry's premier lightweight molded guitar case—just the first of many innovations that have since cemented SKB's global reputation as a leading manufacturer of superior equipment transport solutions. Today, under the guidance and leadership of MPE partners, SKB has expanded its operations into three factories with over 500 employees. SKB's innovative solutions can be found on all seven continents, where they help diverse industries around the world to protect their livelihoods, build better products, and get the job done—usually in the toughest environments where protection of sensitive equipment is mission critical.
For more information on SKB Cases or SKB products, contact the SKB Sales & Marketing Team at (714) 685-5232 or visit www.skbcases.com.
CeeCee Vandiver
SKB Cases
+1 714-685-5232
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
34 minutes ago
- CNN
Trade war: China isn't getting rid of its controls over rare earths, despite 90-day truce with US
Despite a 90-day truce in its trade war with the United States, China appears to be maintaining tight control over its rare earth exports – preserving a key source of leverage in future negotiations amid intensifying strategic rivalry with Washington. As part of last week's trade agreement in Geneva to temporarily roll back tariffs, China pledged to suspend or remove the 'non-tariff' countermeasures it imposed on the US since April 2. That has left businesses scrambling to find out whether that promise applies to China's export controls on seven rare earth minerals and associated products, which were imposed on April 4 as part of its retaliation against US President Donald Trump's 'reciprocal' tariffs on Chinese goods. Magnets made of these heavy rare earth elements are an essential part of everything from iPhones and electric vehicles to big-ticket weapons like F-35 fighter jets and missile systems. Yet their supply is completely dominated by China. Fresh off the plane from the trade talks in Geneva last week, US trade representative Jamieson Greer sought to ease concerns surrounding this potential vulnerability. In a Fox News interview, he answered affirmatively when asked whether China had agreed to lift its export restrictions on rare earths as part of the truce. 'Yep, the Chinese have agreed to remove those countermeasures,' Greer said. 'If they don't do those things, we're going to be back in a different situation. But I expect they'll remove them.' However, there's little sign to suggest China is removing its newly imposed rare earth export control regime. If anything, according to experts and industry insiders, Chinese authorities appear to be strengthening implementation and ramping up oversight. The system, introduced in April, does not ban exports outright, but requires government approval for each shipment. That had caused weeks long holdups as companies navigated the new regime, fueling fears among a wide range of American industries from automobile to defense. 'I would not be shocked to find that Mr Greer is expressing what he hopes will happen versus what has actually been negotiated to happen,' said Jon Hykawy, president of the Toronto-based industry advisory firm Stormcrow Capital. 'These controls are intended … to ensure that China does not run short of some materials that are needed for domestic Chinese priorities,' said Hykawy. Gracelin Baskaran, director of the Critical Minerals Security Program at the Center for Strategic and International Studies (CSIS), said China's export licensing regime is 'here to stay' and 'may stay for a long time,' allowing Beijing to retain its leverage in future trade talks with the US. If the US were to turn around and renege on their tariff policy, China can easily withhold the required licenses, she said, adding that the licensing policy is dynamic by design, giving Beijing the power to decide which companies or countries can access its rare earth minerals and magnets at any given time. Following the Geneva talks, China's Commerce Ministry removed 28 US firms from its dual-use export control list and pulled 17 American companies from another trade and investment backlist. But the ministry made no mention of any changes to the exports control on rare earth minerals and magnets. A spokesperson for the ministry said she had 'no information to share' on whether China is lifting the export controls at a regular news conference last Friday. Instead, Chinese authorities launched a crackdown on the smuggling of critical minerals – a broader category of resources that include rare earth elements. On May 12, the day US and China announced the tariff cuts, Chinese export regulators convened a meeting with authorities from multiple mineral-rich provinces with the aim to 'prevent the illegal outflow of strategic minerals' and 'strengthen oversight across every link of the production and supply chain.' On the same day, Yuyuan Tantian, a social media account affiliated with state broadcaster CCTV, said in a post that 'China's rare earth export controls are continuing.' Meanwhile, after weeks of delay, China has started to issue export permits for rare earth magnets – a development that experts say shows the new licensing system is up and running, rather than restrictions being eased. Two Chinese rare earth magnet producers told CNN they had recently received licenses for exporting products containing dysprosium and terbium – elements that are often added to create more heat resistance in high-performance magnets commonly used in the automobile, aerospace and military industries. The approvals are granted under a 'one batch, one license' rule, meaning a new permit is required for each shipment and cannot be reused, according to the companies. One of the companies received its first export license for a shipment heading to Southeast Asia. It has since been granted several other licenses for exports to Europe, including the carmaker Volkswagen in Germany. 'We haven't received any indications about the (export control) system easing up,' a person close to the company told CNN. Volkswagen said in a statement that its suppliers have received indications that 'a limited number of export licenses have been granted.' Baskaran, from CSIS, said that instead of lifting the export controls on rare earths, China removed 28 American firms from its export control list. That means those companies, mostly aerospace and defense firms, are no longer banned from accessing dual-use materials from China, and their Chinese suppliers can now apply for export licenses for rare earth magnets. But it remains to be seen whether Beijing will ultimately give out licenses to American defense firms. China's rare earth export controls were 'specifically designed to hit the US defense industry, and I cannot envision China stepping back from that,' said Thomas Kruemmer, director of the Singapore-based mineral and metal supply chain firm Ginger International Trade and Investment. Under the new rules, exporters must include information about end-users in their applications, which take up to 45 working days to be approved. 'I am sure that in case of defense contractors, the Chinese Commerce Ministry will raise pesky questions, which the Americans may be unwilling to answer or may need Pentagon permission to answer,' Kruemmer said. 'This way they can conveniently delay the issuance of dual-use product export licenses beyond the self-set 45-day deadline, perhaps even beyond this 90-day (truce) window. And it still has the option to reject the license applications anyway.' The licensing rules can also offer China visibility into where the rare earth magnets end up. 'You can still get the material, but you have to fill out paperwork, describe to China who the end user is. You're going to give all this information and then (China) can see inside your downstream customer base and use and look for further vulnerability,' said James Kennedy, president of Three Consulting, a rare earths consultancy based in St Louis, Missouri. 'So it's very smart. They get a looking glass into what you're doing.' For decades, the US and other countries have been dependent on China's supply of rare earth minerals, which are difficult, costly and environmentally polluting to extract and process. China accounts for 61% of global mined rare earth production, but its control over the processing stage is much higher at 92% of the global output, according to the International Energy Agency. The April export controls are far from the first time Beijing has leveraged its dominance in the industry. In 2010, China halted shipments of rare earths to Japan for nearly two months over a territorial dispute. In late 2023, it imposed a ban on rare earth extraction and separation technologies. Beijing has also curbed exports of other critical minerals that are vital to the economy and global supply chains – including outright bans on the shipments of gallium, germanium, antimony and so-called superhard materials to the US. 'China's control over rare earths, cobalt, gallium and all these critical materials is a geopolitical weapon of never-before measured and seen effect,' Kennedy said. 'And at the end of the day, what this does is, it creates a lot of uncertainty. And that in itself is a powerful weapon.' Baskaran said that by granting some of its first export licenses of rare earth magnets to Volkswagen, China is sending a pointed geopolitical message. 'Germany is at the height of geopolitical crossfire. The US is unhappy that Germany has been overtly quite friendly with China. So, by giving it one of the first licenses, China is sending a very positive signal in the Chinese-German relationship,' she said. 'In this era of rising tension between the world's two geopolitical superpowers, the licensing system may stay as a larger form of power.' CNN's Joyce Jiang contributed reporting.
Associated Press
an hour ago
- Associated Press
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. (URGN) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, all dates inclusive (the 'Class Period'), have until July 28, 2025 to seek appointment as lead plaintiff of the UroGen class action lawsuit. Captioned Cockrell v. UroGen Pharma Ltd., 25-cv-06088 (D.N.J.), the UroGen class action lawsuit charges UroGen as well as certain of UroGen's top current and former executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the UroGen class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: UroGen engages in the development and commercialization of solutions for specialty cancers. According to the complaint, UroGen's lead pipeline product is UGN-102 (mitomycin), an intravesical solution intended to treat low-grade intermediate risk non-muscle invasive bladder cancer. The UroGen class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) UroGen's ENVISION clinical study for UGN-102 was not designed to demonstrate substantial evidence of effectiveness of UGN-102 because it lacked a concurrent control arm; (ii) as a result, UroGen would have difficulty demonstrating that the duration of response endpoint was attributable to UGN-102; (iii) UroGen failed to heed the U.S. Food and Drug Administration's ('FDA') warnings about the study design used to support a new drug application ('NDA') for UGN-102; and (iv) as a result, there was a substantial risk that the NDA for UGN-102 would not be approved. The UroGen class action lawsuit further alleges that on May 16, 2025, the FDA published a briefing document in advance of its Oncologic Drugs Advisory Committee meeting regarding UroGen's NDA for UGN-102, which stated that '[g]iven that ENVISION lacked a concurrent control arm, the primary endpoints of complete response (CR) and duration of response (DOR) are difficult to interpret,' and that the FDA had 'recommended a randomized trial design to the Applicant several times during their product's development due to concerns with interpreting efficacy results' but UroGen 'chose not to conduct a randomized trial with a design and endpoints that the FDA considered appropriate.' On this news, the price of UroGen stock fell nearly 26%, according to the complaint. Then, on May 21, 2025, the UroGen class action lawsuit further alleges that the Oncologic Drugs Advisory Committee voted against approving the UGN-102 NDA, finding that the overall benefit-risk of the investigation therapy UGN-102 is not favorable in patients with recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer. On this news, the price of UroGen stock fell nearly 45%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired UroGen securities during the Class Period to seek appointment as lead plaintiff in the UroGen class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the UroGen class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the UroGen class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the UroGen class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]
Associated Press
an hour ago
- Associated Press
ABL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Abacus Global Management, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Abacus Global Management, Inc. (NASDAQ: ABL) focused on whether Abacus Global and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Abacus Global investigation or if you are an Abacus Global investor who suffered a loss and would like to learn more, you can provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. THE COMPANY: Abacus Global operates as an alternative asset manager and market maker. THE REVELATION: On June 4, 2025, Morpheus Research published a report titled 'Abacus Global Management: This $740 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue By Systematically Underestimating When People Will Die.' On this news, Abacus Global's stock price fell more than 21%. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]
